Firazyr 30 mg/3 ml
Firazyr 30 mg/3 ml is a medicine authorised by Swissmedic under authorisation number 58178. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 June 2009 and the authorisation is valid without a time limit. ATC code B06AC02 places the medicine in the group Other hematological agents.
| Authorisation number | 58178 |
|---|---|
| Name | Firazyr 30 mg/3 ml |
| Full name | Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B06AC02 |
| First authorisation | 17 June 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Firazyr 30 mg/3 ml, Injektionslösung in einer Fertigspritze | B | 17 June 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 3 | ml | B06AC02 | 02.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Firazyr 30 mg/3 ml authorised in Switzerland?
Yes. Firazyr 30 mg/3 ml is authorised by Swissmedic under authorisation number 58178, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Firazyr 30 mg/3 ml have?
Firazyr 30 mg/3 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Firazyr 30 mg/3 ml?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.